Changshu, China

Jianwei Bian


 

Average Co-Inventor Count = 19.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Jianwei Bian

Introduction

Jianwei Bian is an accomplished inventor based in Changshu, China. With two patents to his name, he has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for treating medical conditions.

Latest Patents

One of Jianwei Bian's notable inventions is related to aminopyridine derivatives and their utility as selective ALK-2 inhibitors. This invention includes a compound of formula (I) both in free form and in pharmaceutically acceptable salt form. The patent highlights the compound's potential use in the treatment of conditions such as heterotopic ossification and fibrodysplasia ossificans progressiva. His work in this area indicates a strong focus on advancing therapeutic options in addressing complex medical challenges.

Career Highlights

Jianwei Bian is currently affiliated with Novartis AG, a leading global healthcare company. His role involves extensive research and development in pharmacological innovations, demonstrating his commitment to improving patient care through scientific advancement.

Collaborations

During his career, Jianwei has collaborated with notable colleagues including Luca Arista and Sreehari Babu. These collaborations reflect his ability to work within a team of skilled professionals, contributing to collective inventions and advancements in their respective fields.

Conclusion

Jianwei Bian’s contributions to the pharmaceutical industry through his patents on aminopyridine derivatives underscore the importance of innovation in medicine. His collaborations and ongoing work at Novartis AG continue to foster developments that may significantly impact healthcare practices. With his research, he is poised to make further advancements that could benefit many individuals facing challenging medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…